#Rayaldee
LightNews LightNews
hswapnil.medsky.social
Strange papers published by @asnpublications.bsky.social #K360

journals.lww.com/kidney360/ci...

Written by 3 pharma employees +2, first and corresponding author pharma employee, & ‘perspective’ says ……use the pharma product!

Why should *anyone* use calcefidiol aka OPKO pharma’s Rayaldee™️?
September 9, 2025 at 2:22 PM
katiekwonmd.bsky.social
#Rayaldee approved for 2ndary HPT in CKD3-4 with low Vit D. Better than placebo in trial. So... it's basically Vitamin D?
November 17, 2024 at 4:11 AM
stocktitan.net
#OPK OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

https://www.stocktitan.net/news/OPK/opko-health-expands-nicoya-agreement-to-support-rayaldee-v3iw2k75v6q3.html
Kidney drug RAYALDEE targets China as OPKO takes 15% Nicoya stake
Deal keeps OPKO eligible for up to $115M in milestones as Nicoya moves beyond Macau approval toward China and related territory decisions in 2027.
www.stocktitan.net
April 30, 2026 at 12:30 PM
eurekamag.com
ICYMI: Extended-release calcifediol (Rayaldee) for secondary hyperparathyroidism
Extended-release calcifediol (Rayaldee) for secondary hyperparathyroidism
The FDA has approved extended-release (ER) calcifediol (25-hydroxyvitamin D3; Rayaldee Opko), a prohormone of calcitriol, the active form of vitamin D3. It is indicated for treatment of secondary hyperparathyroidism (SHPT) in adults with st...
eurekamag.com
March 18, 2026 at 7:52 AM
eurekamag.com
Extended-release calcifediol (Rayaldee) for secondary hyperparathyroidism
Extended-release calcifediol (Rayaldee) for secondary hyperparathyroidism
The FDA has approved extended-release (ER) calcifediol (25-hydroxyvitamin D3; Rayaldee Opko), a prohormone of calcitriol, the active form of vitamin D3. It is indicated for treatment of secondary hyperparathyroidism (SHPT) in adults with st...
eurekamag.com
March 17, 2026 at 7:51 AM